SAI acquires Fulcrum Research

The acquisition, which was for an undisclosed amount, was carried out in partnership with private equity firm Northlane Capital Partners (NCP).

The aim of the acquisition is to boost SAI’s growth and consultancy services, and the Fulcrum staff will transfer to SAI as part of the deal.

Fulcrum was founded in 2010 and is based in Massachusetts, US, specialising in healthcare and biopharmaceuticals market research based on direct physician and patient interviews and surveys.

SAI is a consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology and medical device industries.

Erik Nordhoy, founder and chief executive at SAI, said: “Fulcrum and SAI share the same values and commitment to analytical research and top-tier client service, so the fit is natural between the two organisations.

“Fulcrum complements SAI’s core competitive intelligence expertise and enhances our value proposition as a full-service decision support partner to the pharmaceutical and biotech sectors.”

Erik Coats, managing partner at Fulcrum, said: “SAI is an ideal partner for the next stage of Fulcrum’s growth as it provides the opportunity to continue providing our best-in-class market research services, while also leveraging the capabilities and relationships of the SAI platform to augment our services to new and existing clients.”

Eugene Krichevsky, partner at NCP, added: “This combination furthers our goal of building SAI into a premier global consultancy to the pharmaceutical and medical device industries.

“We look forward to continuing to strategically invest in resources to accelerate SAI’s growth and expand its service capabilities.”